XML 97 R67.htm IDEA: XBRL DOCUMENT v3.22.4
Debt (Details) - Summary of borrowings of the scilex pharma notes - USD ($)
Sep. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Debt Instrument [Line Items]      
Current portion $ 0 $ (37,950,000) $ (15,888,000)
Long term portion 0 72,037,000 92,255,000
Scilex Pharma Notes [Member]      
Debt Instrument [Line Items]      
Principal 0 133,997,000 151,872,000
Unamortized debt discount 0 (30,597,000) (51,022,000)
Unamortized debt issuance costs 0 (2,228,000) (3,711,000)
Carrying value 0 101,172,000 97,139,000
Current portion 0 (29,135,000) (4,881,000)
Long term portion 0 72,037,000 92,258
Estimated fair value $ 0 $ 115,400,000 $ 122,300,000